Cargando…
Erratum for: Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Faculdade de Medicina / USP
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811832/ https://www.ncbi.nlm.nih.gov/pubmed/33503197 http://dx.doi.org/10.6061/clinics/2021/e1857err |
Ejemplares similares
-
Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis
por: Xiong, Yan, et al.
Publicado: (2020) -
Erratum. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery. Diabetes Care 2019;42:1956–1965
por: Ceperuelo-Mallafré, Victoria, et al.
Publicado: (2019) -
Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy (Erratum)
por: Sauer, Lydia, et al.
Publicado: (2018) -
The Association between Helicobacter pylori Infection and Irritable Bowel Syndrome: A Meta-Analysis
por: Kim, Yun-A, et al.
Publicado: (2020) -
Is there an association between Helicobacter pylori infection and irritable bowel syndrome? A meta-analysis
por: Ng, Qin Xiang, et al.
Publicado: (2019)